Leukotriene Receptor
Leukotrienes receptors are divided into two types, BLT receptors and CycLT receptors. BLT receptors mediate chemoattraction. CysLT receptors mediate pro-inflammatory effects including constriction of airways ad smooth muscle contraction.
Products for Leukotriene Receptor
- Cat.No. Product Name Information
-
GC69977
(S)-Veliflapon
(S)-Veliflapon ((S)-BAY X 1005) is an orally active leukotriene biosynthesis and 5-lipoxygenase activating protein (FLAP) inhibitor. It inhibits the formation of leukotriene B4 (LTB4) in rat, mouse, and human white blood cells with IC50 values of 0.026 μM, 0.039 μM, and 0.22 μM respectively. (S)-Veliflapon exhibits enantioselectivity in human whole blood.
- GC60425 (S)-Verapamil D7 hydrochloride (S)-Verapamil D7 hydrochloride ((S)-(-)-Verapamil D7 hydrochloride) is a deuterium labeled (S)-Verapamil hydrochloride. (S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) inhibits leukotriene C4 (LTC4) and calcein transport by MRP1. (S)-Verapamil hydrochloride leads to the death of potentially resistant tumor cells.
- GC60008 (S)-Verapamil hydrochloride (S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) inhibits leukotriene C4 (LTC4) and calcein transport by MRP1. (S)-Verapamil hydrochloride leads to the death of potentially resistant tumor cells.
- GC10821 11-keto-β-Boswellic Acid 11-Keto-beta-boswellic acid (11-Keto-β-boswellic acid) is a pentacyclic triterpenic acid of the oleogum resin from the bark of the Boswellia serrate tree, popularly known as Indian Frankincense. 11-Keto-beta-boswellic acid has the anti-inflammatory activity is primarily due to inhibit 5-lipoxygenase (5-LOX) and subsequent leukotriene and nuclear factor-kappa B (NF-κB) activation and tumor necrosis factor alpha generation production.
- GC41883 12(S)-HHTrE 12(S)-HHTrE (12(S)-HHTrE) is an enzymatic product of prostaglandin H2 (PGH2) derived from cyclooxygenase (COX)-mediated arachidonic acid metabolism.
- GC35168 5-O-Demethylnobiletin 5-O-Demethylnobiletin (5-Demethylnobiletin), a polymethoxyflavone isolated from Sideritis tragoriganum, is a direct inhibition of 5-LOX (IC50=0.1 μM), without affecting the expression of COX-2.
- GC64356 Ablukast Ablukast (Ro 23-3544) is a specific and active leukotriene receptor antagonist.
- GC32058 Amelubant (BIIL 284) Amelubant (BIIL 284) (BIIL 284) is a potent, oral and long acting LTB4 receptor antagonist, negligibly binds to LTB4 receptor, with Kis of 221 nM and 230 nM in vital cells and membranes.
- GC11201 ARM1 LTB4 synthesis inhibitor
- GC31774 AS-35 AS-35 is an orally effective, potent and selective antagonist of leukotrienes, antagonizes LTC4-, LTD4 and LTE4-induced contractions of the ileum with IC50 values of 8 nM, 4 nM and 3 nM, respectively, and has antiallergic activities.
- GC10266 BAY-u 9773 Antagonist of CysLT1/CysLT2 receptors
- GC12232 BAY-X 1005 BAY-X 1005 (BAY X 1005; DG-031) is an orally active and selective 5-lipoxygenase activating protein (FLAP) inhibitor.
- GC35517 BIIL-260 hydrochloride BIIL-260 hydrochloride is a potent and long-acting orally active leukotriene B(4) receptor LTB4 antagonist, with anti-inflammatory activity.
- GC13497 BML-111 BML-111, a lipoxin A4 analog, is a lipoxin A4 receptor agonist.
- GC32002 Bunaprolast (U66858) Bunaprolast (U66858) (U66858) is a potent inhibitor of LTB4 production in human whole blood.
- GC31994 CI-949 CI-949 is an allergic mediator release inhibitor, which inhibits histamine, leukotriene C4/D4 (LTC4/LTD4), and thromboxane B2 (TXB2) release with IC50s of 11.4 μM, 0.5 μM and 0.1 μM, respectively.
- GC12230 Cinalukast CysLT1 (LTD4) leukotriene receptor antagonist
- GC32015 CP-105696 (Pfizer 105696) CP-105696 (Pfizer 105696) is a potent and selective Leukotriene B4 Receptor antagonist, with an IC50 of 8.42 nM.
- GC31923 CP-96486 CP-96486 is a potent and orally active leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor antagonist with Kis of 20 and 24 nM, respectively.
- GC38764 Darbufelone Darbufelone is a dual inhibitor of cellular PGF2α and LTB4 production.
- GC30604 Darbufelone mesylate (CI-1004 mesylate) Darbufelone mesylate (CI-1004 mesylate) (CI-1004 mesylate) is a dual inhibitor of cellular PGF2α and LTB4 production.
- GC31921 DW-1350 DW-1350 is a LTB4 receptor antagonist.
- GC11283 FPL 55712 Leukotriene receptor antagonist
- GC32025 Gemilukast (ONO-6950) Gemilukast (ONO-6950) is an orally active and potent dual cysteinyl leukotriene 1 and 2 receptors (CysLT1 and CysLT2) antagonist, with IC50s of 1.7, 25 nM for human CysLT1 and CysLT2, respectively.
- GC17092 HAMI3379 HAMI3379 is the racemate of HAMI 3379.
- GC31986 Iralukast (CGP 45715A)
- GC31983 KP496 KP496 is a selective, dual antagonist for Leukotriene D4 receptor and Thromboxane A2 receptor.
- GC17372 Leukotriene B4 BLT1/BLT2 receptor agonist
- GC30453 LM-1484 LM-1484 is an antagonist of CysLT1 receptor and displays a higher affinity for 3H-LTC4 sites.
- GC31944 LTD4 antagonist 1 LTD4 antagonist 1 is a potent, orally active antagonist of leukotriene D4 (LTD4) with a Ki of 0.57 nM.
- GC10992 LY 255283 BLT2 receptor antagonist
- GC13087 LY171883 leukotriene D4 receptor antagonist, orally active
- GC31963 LY210073 LY210073 is a Leukotriene B4 (LTB4) receptor antagonist with an IC50 of 6.2 nM.
- GC10189 LY223982 potent BLT1 receptor antagonist
- GC44096 LY293111 LY293111 (LY293111), an orally active leukotriene B4 receptor antagonist, inhibits the binding of [3H]LTB4, with a Ki of 25 nM.
-
GC12197
MK 571
leukotriene D4 receptor antagonist, orally active
-
GC14980
MK-571 sodium salt hydrate
MK-571 sodium salt hydrate, as a potent and specific antagonist of leukotriene D4 action, used for treatment of asthma.
- GC31832 MN-001 MN-001 (KCA 757) is a sulfidopeptide leukotriene receptor antagonist, an orally bioavailable anti-inflammatory agent and used for the treatment of asthma.
- GC11006 Montelukast Sodium Leukotriene receptor antagonist
- GC63296 Montelukast-d6
- GC63566 Montelukast-d6 sodium
- GC17000 Nedocromil anti-inflammatory agent
- GC44360 Nedocromil (sodium salt) Nedocromil (sodium salt) suppresses the action or formation of multiple mediators, including histamine, leukotriene C4 (LTC4), and prostaglandin D2 (PGD2).
- GC32011 ONO4057 (ONO-LB457) ONO4057 (ONO-LB457) is a Leukotriene B4 receptor antagonist, with an IC50 of 0.7±0.3 μM.
-
GC14094
Pranlukast
selective antagonist of the cysteinyl leukotrienes (LT) C(4), LTD(4) and LTE(4),
- GC36956 Pranlukast hemihydrate Pranlukast hemihydrate is a highly potent, selective and competitive antagonist of peptide leukotrienes.
- GC31820 Quinotolast sodium (FR71021) Quinotolast sodium (FR71021) in the concentration range of 1-100 μg/mL inhibits histamine, LTC4 and PGD2 release in a concentration-dependent manner.
- GC14939 REV 5901 antagonist of cysteinyl-leukotriene receptors
- GC33780 RG-12525 (NID 525) RG-12525 (NID 525) is a a specific, competitive and orally effective antagonist of the peptidoleukotrienes, LTC4, LTD4 and LTE4, inhibiting LTC4-, LTD4- and LTE4-inducd guinea pig parenchymal strips contractions, with IC50s of 2.6 nM, 2.5 nM and 7 nM, respectively; RG-12525 (NID 525) is also a peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist with IC50 of appr 60 nM and a potent inhibitor of CYP3A4, with a Ki value of 0.5 μM.
- GC31837 RS-601 RS-601 is a novel leukotriene D4 (LTD4)/thromboxane A2 (TxA2) dual receptor antagonist, with antiasthmatic activities.
- GC15298 SR 2640 hydrochloride leukotriene D4 and E4 receptor antagonist
- GC31980 YM158 free base (YM-57158) YM158 free base (YM-57158) is a potent and selective LTD4 and TXA2 receptor antagonist with pA2 values of about 8.87 and 8.81, respectively.
- GC15839 Zafirlukast oral leukotriene receptor antagonist
- GC10283 γ-Linolenic Acid γ-Linolenic Acid, isolated from Perilla frutescens, is an essential fatty acid that cannot be synthesized by humans.
- GC10020 γ-Linolenic Acid methyl ester weak leukotriene B4 (LTB4) receptor antagonist